drugset / Trial / NCT01025284
A Study for Participants With Small-Cell Lung Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Part A: This study evaluates an experimental treatment in participants with extensive-disease in small-cell lung cancer. Part B: This study evaluates an experimental treatment in participants with extensive-disease in small-cell lung cancer.
Timeline
- Start
- 2009-12
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | litronesib | Small molecule | 5 mg/m2 | Intravenous |
| Subject | litronesib | Small molecule | 6 mg/m2 | Intravenous |
| Subject | litronesib | Small molecule | 8 mg/m2 | Intravenous |